NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Direct-to-Consumer Genetic Testing Market size is estimated to grow by USD 1.22 billion from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 12.99% during the forecast period. Growing adoption of direct-to-consumer genetic testing in early disease diagnosis is driving market growth, with a trend towards advances in next-generation genetic sequencing.
However, doubts over analytical and clinical validity poses a challenge - Key market players include 23andMe Holding Co., 24GENETICS S.L.
, Alpha Biolaboratories Ltd., Ancestry, Centrillion Technology Inc., Color Health Inc.
, Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp.
, Helix OpCo LLC, IntelliGenetics, Invitae Corp., Konica Minolta Inc., Laboratory Corp.
Of America Holdings, MyHeritage Ltd., Myriad Genetics Inc., Positive Biosciences, Quest Diagnostics Inc.
, Sonora Quest Laboratories, Victorian Clinical Genetics Services, and Xcode Life. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View your snapshot now Key Market Trends Fueling Growth The direct-to-consumer genetic testing market is experiencing notable growth due to advancements in next-generation genetic testing technologies.
Next-generation sequencing (NGS) technology, in particular, has revolutionized the industry by enabling larg.